Louis R. Verdetto - 02 Dec 2025 Form 4 Insider Report for Strata Critical Medical, Inc. (BLDE)

Reporting relationship: CEO Keystone Perfusion Service
Issuer ticker: BLDE
Reported as of: 02 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Dec 2025, 16:21:39 UTC
Source filing: View source filing
Reporting owner signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto

Key filing fact

Louis R. Verdetto filed Form 4 for Strata Critical Medical, Inc. (BLDE) on 04 Dec 2025.

Key facts

This page summarizes Louis R. Verdetto's Form 4 filing for Strata Critical Medical, Inc. (BLDE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Dec 2025, 16:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002095962 Primary reporting owner

Verdetto Louis R.

Relationship: CEO Keystone Perfusion Service
Address: C/O STRATA CRITICAL MEDICAL, INC., 31 HUDSON YARDS, 14TH FLOOR, NEW YORK
Signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Louis R. Verdetto
Signature date: 04 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value: $0
Shares: +63,918
Change %: +6%
Price: $0.000000
Shares after: 1,133,793
Date: 02 Dec 2025
Ownership: Direct
Footnotes: F1

SRTA holding

Class A common stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 132,232
Date: 02 Dec 2025
Ownership: See Footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting: 25% of the RSUs (rounded down to the nearest whole number) to become vested on September 8, 2026 and then 6.25% (rounded down to the nearest whole number) will vest every 3 months thereafter, with any remaining unvested RSUs to vest on September 8, 2029, subject to the Reporting Person's continued service to the Issuer.

Footnote F2

The reported securities are held by the LOUIS VERDETTO IRREVOCABLE TRUST DATED AUGUST 20 2025 for which the Reporting Person serves as the trustee.